 SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores
SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores
Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores
Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores
IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores
Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores 
              The Initial Public Offering of Ammana Bio Pharma Limited will open for subscription on Wednesday - March 28, 2007. The company is coming out with an IPO of 15,185,855 Equity shares of face value Rs.10 each at a price band of Rs.12 to Rs.14 aggregating Rs.2166.02 Lacs, including promoters contribution aggregating Rs.150.02 Lacs.
The Net issue to the public would aggregate to Rs.2016 Lacs. The issue is through 100% Book Building Process.
Out of the issue, 7,592,928 equity shares are reserved for Qualified Institutional Buyers (QIBs), 2,277,878 shares are reserved for Non Institutional Investors and 5,315,049 shares for Retail Individual Investors (RIIs).
The Equity Shares issued through this IPO are proposed to be listed on the Bombay Stock Exchange Limited ("BSE") (also the Designated Stock Exchange) and the National Stock Exchange of India Limited ("NSE").
The Book Running Lead Managers to the issue is CENTRUM Capital Ltd.
Bigshare Services Pvt Ltd is the Registrar to the issue.
The company's website is Ammana Bio Pharma Limited
Click on this link to access the Prospectus of Ammana Bio Pharma Limited